BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2189516)

  • 21. Antimalarial drug response of Plasmodium falciparum from Zaria, Nigeria.
    Adagu IS; Warhurst DC; Ogala WN; Abdu-Aguye I; Audu LI; Bamgbola FO; Ovwigho UB
    Trans R Soc Trop Med Hyg; 1995; 89(4):422-5. PubMed ID: 7570886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of Plasmodium falciparum to mefloquine-sulphadoxine-pyrimethamine (Fansimef) in vivo and to mefloquine alone in vitro in Nigeria.
    Salako LA; Aderounmu AF; Laoye JO; Makinde JM; Adio RA
    Ann Trop Med Parasitol; 1988 Aug; 82(4):325-30. PubMed ID: 3075441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fansidar resistance in the Philippines.
    Watt G; Padre LP; Tuazon LR; Laughlin LW
    Trans R Soc Trop Med Hyg; 1987; 81(3):521. PubMed ID: 3318028
    [No Abstract]   [Full Text] [Related]  

  • 24. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
    Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
    Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfadoxine and pyrimethamine in the treatment of falciparum malaria in Vietnam.
    Ryan BP
    Med J Aust; 1975 Jan; 1(4):101-3. PubMed ID: 1094249
    [No Abstract]   [Full Text] [Related]  

  • 26. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
    Randriamanjaka JR; Le Bras J; Charmot G; Coulaud JP
    Bull Soc Pathol Exot Filiales; 1989; 82(3):381-4. PubMed ID: 2670291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru.
    Magill AJ; Zegarra J; Garcia C; Marquiño W; Ruebush TK
    Rev Soc Bras Med Trop; 2004; 37(3):279-81. PubMed ID: 15330070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chloroquine resistance in Plasmodium falciparum in KwaZulu, 1983-1988.
    Hansford CF
    S Afr Med J; 1989 Nov; 76(10):546-7. PubMed ID: 2686047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of pyrimethamine/sulfadoxine in uncomplicated severe falciparum malaria in Kenya.
    Nevill CG; Watkins WM
    Lancet; 1990 Jul; 336(8708):185. PubMed ID: 1973506
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
    Deacon HE; Freese JA; Sharp BL
    S Afr Med J; 1994 Jul; 84(7):394-5. PubMed ID: 7709301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fansidar resistant falciparum malaria acquired in South East Asia.
    Black F; Bygbjerg I; Effersøe P; Gomme G; Jepsen S; Jensen GA
    Trans R Soc Trop Med Hyg; 1981; 75(5):715-6. PubMed ID: 7036431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance of mefloquine alone and in combination with sulfadoxine-pyrimethamine in the prophylaxis of malaria.
    Reisinger EC; Horstmann RD; Dietrich M
    Trans R Soc Trop Med Hyg; 1989; 83(4):474-7. PubMed ID: 2694482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Falciparum malaria resistant to chloroquine and fansidar: implications for prophylaxis.
    Herzog C; Kibbler CC; Ellis CJ; Mtawali CV
    Br Med J (Clin Res Ed); 1983 Oct; 287(6397):947-8. PubMed ID: 6412900
    [No Abstract]   [Full Text] [Related]  

  • 34. [The clinical efficacy of and tolerance for lariam (mefloquine) in tropical malaria in the south of the Socialist Republic of Vietnam].
    Shcherbakov AM; Nguyen TL; Chin KA; Chan KT; Rabinovich SA; Nguyen VD; Chan VF; Nguyen TL; Vu TT; Padelt H
    Med Parazitol (Mosk); 1990; (5):57-9. PubMed ID: 2266908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fansimef in the treatment of malaria.
    Prociv P
    Aust N Z J Med; 1989 Aug; 19(4):411. PubMed ID: 2675819
    [No Abstract]   [Full Text] [Related]  

  • 36. Fansidar-resistant Plasmodium falciparum infection from Tanzania.
    Vleugels MP; Wetsteyn JC; Meuwissen JH
    Trop Geogr Med; 1982; 34(3):263-5. PubMed ID: 6758246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam.
    Thanh NV; Cowman AF; Hipgrave D; Kim TB; Phuc BQ; Cong LD; Biggs BA
    Trans R Soc Trop Med Hyg; 2001; 95(5):513-7. PubMed ID: 11706663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria in travelers returning from Kenya: failure of self-treatment with pyrimethamine/sulfadoxine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1989 May; 38(20):363-4. PubMed ID: 2497333
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible sulfadoxine-pyrimethamine resistance in Plasmodium falciparum malaria from Kenya.
    Markwalder KA; Meyer HE
    Trans R Soc Trop Med Hyg; 1982; 76(2):281. PubMed ID: 7048656
    [No Abstract]   [Full Text] [Related]  

  • 40. Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.
    Brockelman CR; Thanomsub B; Bhisutthibhand J
    Southeast Asian J Trop Med Public Health; 1989 Sep; 20(3):371-8. PubMed ID: 2699083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.